CVE-2026-50034: Apollo Pharmacy Blood Glucose Monitoring System Model No. Apg-01 Bt

Medium severity, CVSS 6.5. EPSS: 0.2% chance of exploitation in the next 30 days.

An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.

Affected products

• Apollo Pharmacy Blood Glucose Monitoring System Model No. Apg-01 Bt: version 0x0110_v1.1.0 only

Published 2026-06-19. Last modified 2026-06-22.